Delivery Order SPE2DB25D3306-SPE2DB25FUCJJ
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 27, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) with a ceiling value of $1,768.36. This firm fixed price, competitively awarded delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government, with performance scheduled for...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for 60 tablets of Eliquis 5 mg at a ceiling value of $20,974.50. This competitively awarded, non-set-aside contract was executed on September 5, 2025, with an ultimate completion date of September 8, 2025. The firm fixed price delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on May 12, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This firm fixed-price delivery order carries a ceiling value of $71,179.72 and is scheduled for ultimate completion by May 13, 2025. The award was made through open competition with no set-aside designation and represents a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $16,042.22 by the Defense Logistics Agency (DLA) on August 12, 2025, with an ultimate completion date of August 13, 2025. The award is for the supply of Eliquis 5 mg tablets (60-count units), an anticoagulant medication commonly used in military and federal healthcare systems. This is a firm fixed price delivery order with no set-aside designation,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order for Eliquis 5 mg tablets (60-count units) valued at $7,758.02 by the Defense Logistics Agency. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 8, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $30,882.20 by the Defense Logistics Agency for 60 tablets of Eliquis 5 mg on July 21, 2025. This contract represents a firm fixed price delivery order with an ultimate completion date of July 22, 2025, and is not designated as a set-aside award. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency (DLA) for Eliquis 5 mg tablets (60-count supply) with a ceiling value of $15,544.58. The contract was awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, and utilizes firm fixed pricing. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Eliquis 5 mg tablets (60-count) with a ceiling value of $26,140.92. The contract, awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a firm fixed-price procurement with no set-aside designation. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $3,826.92 by the Defense Logistics Agency for the supply of Eliquis 5 mg tablets (60-count packaging). The award was issued on July 30, 2025, with an ultimate completion date of July 31, 2025, and is structured as a firm fixed price contract with no set-aside designation. The contract represents a competitive award to AmerisourceBergen's Corporate Office, headquartered in Conshohocken, Pennsylvania, where the performance...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a Delivery Order (Contract No. 4569418933) by the Defense Logistics Agency on September 10, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). The firm fixed-price contract has a ceiling value of $20,822.54 and an ultimate completion date of September 11, 2025. This award was made without a set-aside designation, indicating competitive procurement. The contract represents a continuation of...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCJJDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency valued at $12,471.65 for supply of Eliquis 5 mg tablets (60-count units). This competitive, non-set-aside award utilizes firm fixed pricing and is scheduled for completion by July 29, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026, which authorizes the company to supply a broad portfolio of brand-name and generic pharmaceuticals, vaccines, and medical supplies to support military healthcare programs worldwide. This delivery order represents a routine pharmaceutical procurement supporting the Defense Health Agency and other federal healthcare systems. AmerisourceBergen's extensive federal contract portfolio demonstrates its capability to meet competitive federal procurement requirements across multiple therapeutic domains. The award reflects the company's established role as a critical vendor for military medical supply chains, with consistent awards for both routine commodities and specialty medications delivered through the DLA Troop Support Medical framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.5k | 7/28/25 |